FI68824C - Foerfarande foer framstaellning av terapeutiskt effektiva substituerade 2-etenyl-4-oxo-4h-pyrido(1,2-a)pyrimidiner - Google Patents
Foerfarande foer framstaellning av terapeutiskt effektiva substituerade 2-etenyl-4-oxo-4h-pyrido(1,2-a)pyrimidiner Download PDFInfo
- Publication number
- FI68824C FI68824C FI801464A FI801464A FI68824C FI 68824 C FI68824 C FI 68824C FI 801464 A FI801464 A FI 801464A FI 801464 A FI801464 A FI 801464A FI 68824 C FI68824 C FI 68824C
- Authority
- FI
- Finland
- Prior art keywords
- pyrido
- oxo
- trans
- pyrimidine
- carboxylic acid
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title description 2
- 235000013399 edible fruits Nutrition 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 109
- 150000003839 salts Chemical class 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000002541 furyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- PBILEGHXZXYWMZ-UHFFFAOYSA-N C(=C)C1=CC(=O)N2C(=N1)C=CC=C2 Chemical class C(=C)C1=CC(=O)N2C(=N1)C=CC=C2 PBILEGHXZXYWMZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- -1 6,7-methylene compounds Chemical class 0.000 description 77
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 34
- 239000000203 mixture Substances 0.000 description 28
- 239000002253 acid Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 239000002244 precipitate Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 17
- 229920002554 vinyl polymer Polymers 0.000 description 17
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 150000002576 ketones Chemical class 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
- 150000004702 methyl esters Chemical class 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 239000005457 ice water Substances 0.000 description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 230000003266 anti-allergic effect Effects 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Chemical group 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000005888 cyclopropanation reaction Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
- PNWRNPXJVJQYSL-BQYQJAHWSA-N 6-ethyl-5-[(e)-2-(3-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC(OC)=C1 PNWRNPXJVJQYSL-BQYQJAHWSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 3
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ATSOAUIOEMZMPB-VQHVLOKHSA-N 3-ethyl-2-[(E)-2-(3-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC=CC(C)=C1 ATSOAUIOEMZMPB-VQHVLOKHSA-N 0.000 description 2
- YVXHRAYXYLVPEG-PKNBQFBNSA-N 4-oxo-2-[(e)-2-phenylethenyl]-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1 YVXHRAYXYLVPEG-PKNBQFBNSA-N 0.000 description 2
- LBMGFLVZIOZDHZ-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1C=CN=C2C=CC(C(=O)O)=CN21 LBMGFLVZIOZDHZ-UHFFFAOYSA-N 0.000 description 2
- BVKQXWYMYGFJTB-CMDGGOBGSA-N 5-[(e)-2-(2,3-dimethoxyphenyl)ethenyl]-6-ethyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC(OC)=C1OC BVKQXWYMYGFJTB-CMDGGOBGSA-N 0.000 description 2
- ZOZBRCKHXFEHNY-MDZDMXLPSA-N 5-[(e)-2-(2,3-dimethoxyphenyl)ethenyl]-7-oxo-6-propyl-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OC)=C1OC ZOZBRCKHXFEHNY-MDZDMXLPSA-N 0.000 description 2
- MJNHRVXHFOOLFY-BQYQJAHWSA-N 6-methyl-7-oxo-5-[(e)-2-phenylethenyl]-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(C)=C1\C=C\C1=CC=CC=C1 MJNHRVXHFOOLFY-BQYQJAHWSA-N 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- SPHZEUOGHAABOU-UHFFFAOYSA-N O=C1CC(=C)N=C2C=CC(C(=O)O)=CN21 Chemical compound O=C1CC(=C)N=C2C=CC(C(=O)O)=CN21 SPHZEUOGHAABOU-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 125000004997 halocarbonyl group Chemical group 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 229910052740 iodine Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- UVUGLWDLUNQCJT-VQHVLOKHSA-N 2-[(E)-2-(2,5-dimethylphenyl)ethenyl]-3-ethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CC)=C1\C=C\C1=CC(C)=CC=C1C UVUGLWDLUNQCJT-VQHVLOKHSA-N 0.000 description 1
- UEIGCVITHYNLAK-ACCUITESSA-N 2-[(e)-2-(2,3-diethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OCC)=C1OCC UEIGCVITHYNLAK-ACCUITESSA-N 0.000 description 1
- SCRFNCILGQWUHE-GORDUTHDSA-N 2-[(e)-2-(2,4-dichlorophenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C=1C(=O)N2C=C(C(=O)O)C=CC2=NC=1\C=C\C1=CC=C(Cl)C=C1Cl SCRFNCILGQWUHE-GORDUTHDSA-N 0.000 description 1
- KNKYSNAAAFEGNW-CSKARUKUSA-N 2-[(e)-2-(2,4-dimethylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(C)C=C1C KNKYSNAAAFEGNW-CSKARUKUSA-N 0.000 description 1
- HPZKVBSEEAVINQ-FNORWQNLSA-N 2-[(e)-2-(2,4-dimethylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC(C)=CC=C1\C=C\C1=CC(=O)N(C=C(C=C2)C(O)=O)C2=N1 HPZKVBSEEAVINQ-FNORWQNLSA-N 0.000 description 1
- IETCCNQTKKAWMJ-QPJJXVBHSA-N 2-[(e)-2-(2,5-dimethoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=C(OC)C(\C=C\C2=C(C(=O)N3C=C(C=CC3=N2)C(O)=O)C)=C1 IETCCNQTKKAWMJ-QPJJXVBHSA-N 0.000 description 1
- PKAODLMYLFHFBV-RMKNXTFCSA-N 2-[(e)-2-(2,5-dimethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC(OC)=CC=C1OC PKAODLMYLFHFBV-RMKNXTFCSA-N 0.000 description 1
- OGBYXZYSQDUUBY-FNORWQNLSA-N 2-[(e)-2-(2-chlorophenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C=1C(=O)N2C=C(C(=O)O)C=CC2=NC=1\C=C\C1=CC=CC=C1Cl OGBYXZYSQDUUBY-FNORWQNLSA-N 0.000 description 1
- CBWYZIHBAWXITJ-ZRDIBKRKSA-N 2-[(e)-2-(2-ethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1OCC CBWYZIHBAWXITJ-ZRDIBKRKSA-N 0.000 description 1
- HDFPUDCGZNYXRS-SOFGYWHQSA-N 2-[(e)-2-(2-methoxyphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=CC=C1\C=C\C1=CC(=O)N(C=C(C=C2)C(O)=O)C2=N1 HDFPUDCGZNYXRS-SOFGYWHQSA-N 0.000 description 1
- NNJFRARRNSPGFB-PKNBQFBNSA-N 2-[(e)-2-(2-methylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1C NNJFRARRNSPGFB-PKNBQFBNSA-N 0.000 description 1
- DZRRQQLDFRNBQX-SOFGYWHQSA-N 2-[(e)-2-(2-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC=CC=C1\C=C\C1=CC(=O)N(C=C(C=C2)C(O)=O)C2=N1 DZRRQQLDFRNBQX-SOFGYWHQSA-N 0.000 description 1
- BVTBNNWVOOESOL-QPJJXVBHSA-N 2-[(e)-2-(3,4-dimethoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C1=C(C)C(=O)N2C=C(C(O)=O)C=CC2=N1 BVTBNNWVOOESOL-QPJJXVBHSA-N 0.000 description 1
- JWRAXVWZONFDNO-RMKNXTFCSA-N 2-[(e)-2-(3,4-dimethoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(OC)C(OC)=C1 JWRAXVWZONFDNO-RMKNXTFCSA-N 0.000 description 1
- FTDNJRKTOUVQTL-ZRDIBKRKSA-N 2-[(e)-2-(3-ethoxy-2-methoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OCC)=C1OC FTDNJRKTOUVQTL-ZRDIBKRKSA-N 0.000 description 1
- RQWIYAGZDKHQJT-GQCTYLIASA-N 2-[(e)-2-(3-hydroxyphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C=1C(=O)N2C=C(C(=O)O)C=CC2=NC=1\C=C\C1=CC=CC(O)=C1 RQWIYAGZDKHQJT-GQCTYLIASA-N 0.000 description 1
- WIAKUXSZKOKEBR-CSKARUKUSA-N 2-[(e)-2-(3-methoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OC)=C1 WIAKUXSZKOKEBR-CSKARUKUSA-N 0.000 description 1
- RRXKKGFZOQKHSK-FNORWQNLSA-N 2-[(e)-2-(3-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC=CC(\C=C\C=2N=C3C=CC(=CN3C(=O)C=2)C(O)=O)=C1 RRXKKGFZOQKHSK-FNORWQNLSA-N 0.000 description 1
- BURXQGCIGDOFFW-XBXARRHUSA-N 2-[(e)-2-(4-chlorophenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=C(Cl)C=C1 BURXQGCIGDOFFW-XBXARRHUSA-N 0.000 description 1
- WQHBGECJDHJXFB-WEVVVXLNSA-N 2-[(e)-2-(4-methoxyphenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=CC(OC)=CC=C1\C=C\C1=C(C)C(=O)N2C=C(C(O)=O)C=CC2=N1 WQHBGECJDHJXFB-WEVVVXLNSA-N 0.000 description 1
- QZGPTLMAZJQITC-YRNVUSSQSA-N 2-[(e)-2-(4-methoxyphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(OC)C=C1 QZGPTLMAZJQITC-YRNVUSSQSA-N 0.000 description 1
- WJQTVMXTAYBVKO-PKNBQFBNSA-N 2-[(e)-2-(4-methylphenyl)ethenyl]-4-oxo-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=C(C)C=C1 WJQTVMXTAYBVKO-PKNBQFBNSA-N 0.000 description 1
- NEQDYZLCEWAVPX-AATRIKPKSA-N 2-[(e)-2-(furan-2-yl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CO1 NEQDYZLCEWAVPX-AATRIKPKSA-N 0.000 description 1
- ATLKDUSIEAEVMC-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)ethenyl]-3-methyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1C=CC1=CC=C(Cl)C(Cl)=C1 ATLKDUSIEAEVMC-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- JWDSCUIQYJUHHM-UHFFFAOYSA-N 2-ethylacetoacetic acid Chemical compound CCC(C(C)=O)C(O)=O JWDSCUIQYJUHHM-UHFFFAOYSA-N 0.000 description 1
- WIALVETYYPLERK-UHFFFAOYSA-N 2-methyl-4-oxo-3h-pyrido[1,2-a]pyrimidine-2-carboxylic acid Chemical class C1=CC=CC2=NC(C)(C(O)=O)CC(=O)N21 WIALVETYYPLERK-UHFFFAOYSA-N 0.000 description 1
- GCXJINGJZAOJHR-UHFFFAOYSA-N 2-methylacetoacetic acid Chemical compound CC(=O)C(C)C(O)=O GCXJINGJZAOJHR-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ILHXOWDVNXAXOE-ZRDIBKRKSA-N 3-butyl-2-[(E)-2-(2-methylphenyl)ethenyl]-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCCC)=C1\C=C\C1=CC=CC=C1C ILHXOWDVNXAXOE-ZRDIBKRKSA-N 0.000 description 1
- MWHNTGGIOOKBRO-ZRDIBKRKSA-N 3-butyl-4-oxo-2-[(e)-2-phenylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCCC)=C1\C=C\C1=CC=CC=C1 MWHNTGGIOOKBRO-ZRDIBKRKSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- LRUNQFWAOXIRIR-FNORWQNLSA-N 3-methyl-4-oxo-2-[(e)-2-(3,4,5-trimethoxyphenyl)ethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(\C=C\C2=C(C(=O)N3C=C(C=CC3=N2)C(O)=O)C)=C1 LRUNQFWAOXIRIR-FNORWQNLSA-N 0.000 description 1
- KGBJXKLZZUNXQI-VQHVLOKHSA-N 3-methyl-4-oxo-2-[(e)-2-phenylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(C)=C1\C=C\C1=CC=CC=C1 KGBJXKLZZUNXQI-VQHVLOKHSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ALDGYYJHLPZOAS-ZRDIBKRKSA-N 4-oxo-2-[(e)-2-(2-propan-2-yloxyphenyl)ethenyl]-3-propylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1OC(C)C ALDGYYJHLPZOAS-ZRDIBKRKSA-N 0.000 description 1
- BXQZNAHOISLRQA-UHFFFAOYSA-N 4-oxo-2-prop-1-enylpyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C(=CC)C=1N=C2N(C(C=1)=O)C=C(C=C2)C(=O)O BXQZNAHOISLRQA-UHFFFAOYSA-N 0.000 description 1
- YMVQWGHVYVNJFD-VQHVLOKHSA-N 4-oxo-3-propyl-2-[(e)-2-(2,4,5-trimethoxyphenyl)ethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC(OC)=C(OC)C=C1OC YMVQWGHVYVNJFD-VQHVLOKHSA-N 0.000 description 1
- GHTOWQFLZXQLOA-CMDGGOBGSA-N 4-oxo-3-propyl-2-[(e)-2-pyridin-2-ylethenyl]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound N1=C2C=CC(C(O)=O)=CN2C(=O)C(CCC)=C1\C=C\C1=CC=CC=N1 GHTOWQFLZXQLOA-CMDGGOBGSA-N 0.000 description 1
- LRGYROPNWVVYOS-VOTSOKGWSA-N 5-[(e)-2-(2,5-dimethylphenyl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CC1=CC=C(C)C(\C=C\C2=C(C(=O)N3C4CC4(C=CC3=N2)C(O)=O)C)=C1 LRGYROPNWVVYOS-VOTSOKGWSA-N 0.000 description 1
- NCTFKSXRFBWILS-AATRIKPKSA-N 5-[(e)-2-(2,5-dimethylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CC1=CC=C(C)C(\C=C\C=2N=C3C=CC4(CC4N3C(=O)C=2)C(O)=O)=C1 NCTFKSXRFBWILS-AATRIKPKSA-N 0.000 description 1
- FBSYEUUDXAJPPE-VOTSOKGWSA-N 5-[(e)-2-(2-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound COC1=CC=CC=C1\C=C\C1=CC(=O)N(C2C(C2)(C=C2)C(O)=O)C2=N1 FBSYEUUDXAJPPE-VOTSOKGWSA-N 0.000 description 1
- MVICWEAAKPWOGX-MDZDMXLPSA-N 5-[(e)-2-(2-methoxyphenyl)ethenyl]-7-oxo-6-propyl-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=CC=C1OC MVICWEAAKPWOGX-MDZDMXLPSA-N 0.000 description 1
- XGKNWMLGZIMBHS-VOTSOKGWSA-N 5-[(e)-2-(2-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CC1=CC=CC=C1\C=C\C1=CC(=O)N(C2C(C2)(C=C2)C(O)=O)C2=N1 XGKNWMLGZIMBHS-VOTSOKGWSA-N 0.000 description 1
- NNMZQCMESMNNGO-AATRIKPKSA-N 5-[(e)-2-(3-chlorophenyl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(C)=C1\C=C\C1=CC=CC(Cl)=C1 NNMZQCMESMNNGO-AATRIKPKSA-N 0.000 description 1
- CHQPPAFQODDMBA-MDZDMXLPSA-N 5-[(e)-2-(3-ethoxy-2-methoxyphenyl)ethenyl]-6-ethyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CCOC1=CC=CC(\C=C\C2=C(C(=O)N3C4CC4(C=CC3=N2)C(O)=O)CC)=C1OC CHQPPAFQODDMBA-MDZDMXLPSA-N 0.000 description 1
- HXPHIJLJHWGSLJ-AATRIKPKSA-N 5-[(e)-2-(3-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C=2N=C3C=CC4(CC4N3C(=O)C=2)C(O)=O)=C1 HXPHIJLJHWGSLJ-AATRIKPKSA-N 0.000 description 1
- FJFNWYPSOAMGGJ-CMDGGOBGSA-N 5-[(e)-2-(3-methoxyphenyl)ethenyl]-7-oxo-6-propyl-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=CC(OC)=C1 FJFNWYPSOAMGGJ-CMDGGOBGSA-N 0.000 description 1
- PTDGNVMTYQMPKM-AATRIKPKSA-N 5-[(e)-2-(3-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CC1=CC=CC(\C=C\C=2N=C3C=CC4(CC4N3C(=O)C=2)C(O)=O)=C1 PTDGNVMTYQMPKM-AATRIKPKSA-N 0.000 description 1
- CIFPBDLRHSEEDD-VMPITWQZSA-N 5-[(e)-2-(4-methoxyphenyl)ethenyl]-6-methyl-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound C1=CC(OC)=CC=C1\C=C\C1=C(C)C(=O)N2C3CC3(C(O)=O)C=CC2=N1 CIFPBDLRHSEEDD-VMPITWQZSA-N 0.000 description 1
- QZRMUFZJZUWCNP-VOTSOKGWSA-N 5-[(e)-2-(4-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound C1=CC(C)=CC=C1\C=C\C1=CC(=O)N(C2C(C2)(C=C2)C(O)=O)C2=N1 QZRMUFZJZUWCNP-VOTSOKGWSA-N 0.000 description 1
- ZCIFWRHIEBXBOY-UHFFFAOYSA-N 6-aminonicotinic acid Chemical compound NC1=CC=C(C(O)=O)C=N1 ZCIFWRHIEBXBOY-UHFFFAOYSA-N 0.000 description 1
- MYOTVYWWGPOZGW-CMDGGOBGSA-N 6-ethyl-5-[(e)-2-(2-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1OC MYOTVYWWGPOZGW-CMDGGOBGSA-N 0.000 description 1
- GSYNZJYYKAXPCD-BQYQJAHWSA-N 6-ethyl-5-[(e)-2-(3-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC(C)=C1 GSYNZJYYKAXPCD-BQYQJAHWSA-N 0.000 description 1
- INGRXJPPWZZMHA-RMKNXTFCSA-N 6-ethyl-5-[(e)-2-(4-methoxyphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=C(OC)C=C1 INGRXJPPWZZMHA-RMKNXTFCSA-N 0.000 description 1
- WZZJIHMWWUMTTN-CMDGGOBGSA-N 6-ethyl-7-oxo-5-[(e)-2-phenylethenyl]-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC=CC=C1 WZZJIHMWWUMTTN-CMDGGOBGSA-N 0.000 description 1
- ZFQIRULKYZSONF-BQYQJAHWSA-N 6-methyl-5-[(e)-2-(2-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound CC1=CC=CC=C1\C=C\C1=C(C)C(=O)N2C3CC3(C(O)=O)C=CC2=N1 ZFQIRULKYZSONF-BQYQJAHWSA-N 0.000 description 1
- ILLWEITWEUJRQY-BQYQJAHWSA-N 6-methyl-5-[(e)-2-(4-methylphenyl)ethenyl]-7-oxo-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound C1=CC(C)=CC=C1\C=C\C1=C(C)C(=O)N2C3CC3(C(O)=O)C=CC2=N1 ILLWEITWEUJRQY-BQYQJAHWSA-N 0.000 description 1
- MUBLGVAZTADGNO-VOTSOKGWSA-N 7-oxo-5-[(e)-2-phenylethenyl]-1,8a-dihydrocyclopropa[1,2]pyrido[3,6-c]pyrimidine-1a-carboxylic acid Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2)=O)C1=NC=2\C=C\C1=CC=CC=C1 MUBLGVAZTADGNO-VOTSOKGWSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OISQEMXFJQEMFZ-UHFFFAOYSA-N 9,10-dimethyl-11-oxo-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound CC=1N=C2N(C(C=1C)=O)C1C(C=C2)(C(=O)O)C1 OISQEMXFJQEMFZ-UHFFFAOYSA-N 0.000 description 1
- FAZBYOIXTBSMBV-BQYQJAHWSA-N 9-[(E)-2-(2,3-dimethoxyphenyl)ethenyl]-10-methyl-11-oxo-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound COC1=CC=CC(\C=C\C2=C(C(=O)N3C4CC4(C=CC3=N2)C(O)=O)C)=C1OC FAZBYOIXTBSMBV-BQYQJAHWSA-N 0.000 description 1
- IADARLALJNGAGK-BQYQJAHWSA-N 9-[(E)-2-(2,5-dimethylphenyl)ethenyl]-10-ethyl-11-oxo-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CC)=C1\C=C\C1=CC(C)=CC=C1C IADARLALJNGAGK-BQYQJAHWSA-N 0.000 description 1
- UELULVRTUHCYSB-SOFGYWHQSA-N 9-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-11-oxo-10-propyl-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylic acid Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1\C=C\C1=CC=C(OC)C(OC)=C1 UELULVRTUHCYSB-SOFGYWHQSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PUROAYYDPUDKMW-CMDGGOBGSA-N C1(=CC=CC=C1)/C=C/C=1N=C2N(CC1CC)C1C(C=C2)(C(=O)O)C1 Chemical compound C1(=CC=CC=C1)/C=C/C=1N=C2N(CC1CC)C1C(C=C2)(C(=O)O)C1 PUROAYYDPUDKMW-CMDGGOBGSA-N 0.000 description 1
- STAVUADEZMNEET-SOFGYWHQSA-N CC1=C(N=C2C=CC3=C(C3)N2C1=O)/C=C/C4=CC(=CC=C4)OC Chemical compound CC1=C(N=C2C=CC3=C(C3)N2C1=O)/C=C/C4=CC(=CC=C4)OC STAVUADEZMNEET-SOFGYWHQSA-N 0.000 description 1
- BRJCJAMOXBYZNP-UHFFFAOYSA-N CCC1=CN=C2C=CC(=CN2C1=O)C(=O)O Chemical compound CCC1=CN=C2C=CC(=CN2C1=O)C(=O)O BRJCJAMOXBYZNP-UHFFFAOYSA-N 0.000 description 1
- AGNRGONCMOTRKA-PKNBQFBNSA-N CCCC1=CN=C2C=CC3(CC3N2C1=O)C(=O)O/C=C/C4=CC=CC(=C4)C Chemical compound CCCC1=CN=C2C=CC3(CC3N2C1=O)C(=O)O/C=C/C4=CC=CC(=C4)C AGNRGONCMOTRKA-PKNBQFBNSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101100079846 Homo sapiens NEU1 gene Proteins 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- LEWSFKKVNFJPPT-UHFFFAOYSA-N N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1C=CC1=CC(OC)=CC(OC)=C1 Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1C=CC1=CC(OC)=CC(OC)=C1 LEWSFKKVNFJPPT-UHFFFAOYSA-N 0.000 description 1
- ODPRAIJUUVLDQP-UHFFFAOYSA-N N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1C=CC1=CC(OC)=CC=C1OC Chemical compound N1=C2C=CC3(C(O)=O)CC3N2C(=O)C(CCC)=C1C=CC1=CC(OC)=CC=C1OC ODPRAIJUUVLDQP-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 102100028760 Sialidase-1 Human genes 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- PJWSWBRTZKODSD-UHFFFAOYSA-N acetic acid;benzene;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O.C1=CC=CC=C1 PJWSWBRTZKODSD-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002288 cocrystallisation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- VHOACUZAQKMOEQ-UHFFFAOYSA-N ethyl 2-acetylpentanoate Chemical compound CCCC(C(C)=O)C(=O)OCC VHOACUZAQKMOEQ-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- JIQNWFBLYKVZFY-UHFFFAOYSA-N methoxycyclohexatriene Chemical class COC1=C[C]=CC=C1 JIQNWFBLYKVZFY-UHFFFAOYSA-N 0.000 description 1
- QQXDJRGWSOUAHV-MDZDMXLPSA-N methyl 10-ethyl-11-oxo-9-[(E)-2-phenylethenyl]-1,8-diazatricyclo[5.4.0.02,4]undeca-5,7,9-triene-4-carboxylate Chemical compound COC(=O)C12C=CC=3N(C(C(=C(N=3)\C=C\C3=CC=CC=C3)CC)=O)C1C2 QQXDJRGWSOUAHV-MDZDMXLPSA-N 0.000 description 1
- OGUAQCAUEFJRKP-UHFFFAOYSA-N methyl 2,3-dimethyl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylate Chemical compound COC(=O)C=1C=CC=2N(C(C(=C(N=2)C)C)=O)C=1 OGUAQCAUEFJRKP-UHFFFAOYSA-N 0.000 description 1
- JACPDLJUQLKABC-UHFFFAOYSA-N methyl 6-aminopyridine-3-carboxylate Chemical compound COC(=O)C1=CC=C(N)N=C1 JACPDLJUQLKABC-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YPLIFKZBNCNJJN-UHFFFAOYSA-N n,n-bis(ethylamino)ethanamine Chemical compound CCNN(CC)NCC YPLIFKZBNCNJJN-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical group OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- BWESROVQGZSBRX-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine Chemical group C1=NC=NC2=CC=CN=C21 BWESROVQGZSBRX-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LYIQCFVNCQKBHH-UHFFFAOYSA-N trisodium ethanolate Chemical compound [O-]CC.[O-]CC.[O-]CC.[Na+].[Na+].[Na+] LYIQCFVNCQKBHH-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7915810 | 1979-05-08 | ||
| GB7915810 | 1979-05-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI801464A7 FI801464A7 (fi) | 1980-11-09 |
| FI68824B FI68824B (fi) | 1985-07-31 |
| FI68824C true FI68824C (fi) | 1985-11-11 |
Family
ID=10504995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI801464A FI68824C (fi) | 1979-05-08 | 1980-05-06 | Foerfarande foer framstaellning av terapeutiskt effektiva substituerade 2-etenyl-4-oxo-4h-pyrido(1,2-a)pyrimidiner |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4310526A (cs) |
| JP (1) | JPS562983A (cs) |
| AT (1) | AT375370B (cs) |
| AU (1) | AU527931B2 (cs) |
| BE (1) | BE883150A (cs) |
| CA (1) | CA1134359A (cs) |
| CH (1) | CH647777A5 (cs) |
| CS (2) | CS528780A2 (cs) |
| DE (1) | DE3015738A1 (cs) |
| DK (1) | DK200280A (cs) |
| ES (1) | ES8104287A1 (cs) |
| FI (1) | FI68824C (cs) |
| FR (1) | FR2456093A1 (cs) |
| GB (1) | GB2050353B (cs) |
| GR (1) | GR68075B (cs) |
| HU (1) | HU181778B (cs) |
| IE (1) | IE49787B1 (cs) |
| IL (1) | IL59802A (cs) |
| IT (1) | IT1209326B (cs) |
| LU (1) | LU82419A1 (cs) |
| NL (1) | NL8002656A (cs) |
| NO (1) | NO153137C (cs) |
| NZ (1) | NZ193579A (cs) |
| PH (1) | PH16695A (cs) |
| PT (1) | PT71197A (cs) |
| SE (1) | SE437158B (cs) |
| SU (2) | SU1217259A3 (cs) |
| ZA (1) | ZA802390B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT377586B (de) | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
| US4537962A (en) * | 1982-02-04 | 1985-08-27 | Farmitalia Carlo Erba, S.P.A. | Substituted 1,3,4-thiadiazolo[3,2-A]pyrimidines and compositions containing them |
| CA1211111A (en) * | 1982-02-15 | 1986-09-09 | Isao Yanagisawa | Process for preparing novel pyrimidone compounds |
| ES521739A0 (es) * | 1982-04-29 | 1984-07-01 | Erba Farmitalia | Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas. |
| IL69274A (en) * | 1982-08-05 | 1986-08-31 | Erba Farmitalia | (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them |
| GB8300728D0 (en) * | 1983-01-12 | 1983-02-16 | Erba Farmitalia | Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives |
| US4457932A (en) * | 1983-07-22 | 1984-07-03 | Bristol-Myers Company | Anti-ulcer agents |
| GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| JP2668259B2 (ja) * | 1988-02-18 | 1997-10-27 | 塩野義製薬株式会社 | 複素環化合物および抗潰瘍剤 |
| CA2724008A1 (en) * | 2008-01-11 | 2009-09-11 | Prasada Rao V.S. Lingam | Fused pyrimidine derivatives as trpv3 modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209622A (en) * | 1973-03-30 | 1980-06-24 | Chinoin Gygyszer es Vegyeszeti Termekek Gyara Rt. | 3-(Ethoxycarbonyl-methyl)-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine |
| US3935197A (en) * | 1975-05-16 | 1976-01-27 | E. R. Squibb & Sons, Inc. | 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones |
| HU178910B (en) | 1977-08-19 | 1982-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines |
| HU184058B (en) | 1977-12-29 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new compounds with nitrogen bridge head |
| HU180701B (en) | 1977-12-29 | 1983-04-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering |
-
1980
- 1980-04-10 IL IL59802A patent/IL59802A/xx unknown
- 1980-04-10 US US06/138,879 patent/US4310526A/en not_active Expired - Lifetime
- 1980-04-10 AU AU57319/80A patent/AU527931B2/en not_active Ceased
- 1980-04-17 GB GB8012638A patent/GB2050353B/en not_active Expired
- 1980-04-18 PH PH23918A patent/PH16695A/en unknown
- 1980-04-21 ZA ZA00802390A patent/ZA802390B/xx unknown
- 1980-04-23 GR GR61754A patent/GR68075B/el unknown
- 1980-04-24 DE DE19803015738 patent/DE3015738A1/de not_active Withdrawn
- 1980-04-30 NZ NZ193579A patent/NZ193579A/xx unknown
- 1980-05-05 LU LU82419A patent/LU82419A1/fr unknown
- 1980-05-06 IT IT8021821A patent/IT1209326B/it active
- 1980-05-06 FI FI801464A patent/FI68824C/fi not_active IP Right Cessation
- 1980-05-07 SE SE8003433A patent/SE437158B/sv not_active IP Right Cessation
- 1980-05-07 CH CH3571/80A patent/CH647777A5/de not_active IP Right Cessation
- 1980-05-07 ES ES491238A patent/ES8104287A1/es not_active Expired
- 1980-05-07 SU SU802917352A patent/SU1217259A3/ru active
- 1980-05-07 IE IE945/80A patent/IE49787B1/en unknown
- 1980-05-07 DK DK200280A patent/DK200280A/da not_active Application Discontinuation
- 1980-05-07 BE BE2/500A patent/BE883150A/fr not_active IP Right Cessation
- 1980-05-07 NO NO801342A patent/NO153137C/no unknown
- 1980-05-07 CS CS805287A patent/CS528780A2/cs unknown
- 1980-05-07 CA CA000351417A patent/CA1134359A/en not_active Expired
- 1980-05-07 PT PT71197A patent/PT71197A/pt unknown
- 1980-05-07 HU HU801121A patent/HU181778B/hu unknown
- 1980-05-07 CS CS803213A patent/CS244107B2/cs unknown
- 1980-05-08 AT AT0245680A patent/AT375370B/de not_active IP Right Cessation
- 1980-05-08 JP JP6001780A patent/JPS562983A/ja active Pending
- 1980-05-08 FR FR8010290A patent/FR2456093A1/fr active Granted
- 1980-05-08 NL NL8002656A patent/NL8002656A/nl not_active Application Discontinuation
-
1981
- 1981-05-27 US US06/267,450 patent/US4341780A/en not_active Expired - Fee Related
- 1981-06-24 SU SU813308438A patent/SU1158045A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0091241B1 (en) | Condensed pyrrolinone derivatives, and their production | |
| US6160119A (en) | Fused dihydropyrans | |
| CS254992B2 (en) | Method of thieno-triazolo-1,4-diazepino-2-carboxyl acids' new amides production | |
| FI68824C (fi) | Foerfarande foer framstaellning av terapeutiskt effektiva substituerade 2-etenyl-4-oxo-4h-pyrido(1,2-a)pyrimidiner | |
| PL132141B1 (en) | Process for preparing novel derivatives of dibenzoimidazoazepins | |
| AU740578B2 (en) | Tetrahydropyrido compounds | |
| US4912104A (en) | Tricyclic fused pryimidine derivatives, and their use as pharmaceuticals | |
| US5527796A (en) | Thienothiazine derivatives and their use | |
| GB2061944A (en) | New pyridothienotriazines | |
| PL140595B1 (en) | Method of obtaining novel derivatives of 1h,3h-pyrolo/1,2-c/-thiasoles | |
| US3519628A (en) | Aralkyl diazabicyclo(4,4,0)decanes | |
| EP0229823B1 (en) | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives | |
| CA1154766A (en) | Antiallergic nitrogen bridgehead compounds and process for the preparation thereof | |
| US3949081A (en) | 4-Carbamoyl-1-benzazepines as antiinflammatory agents | |
| FI77869C (fi) | Foerfarande foer framstaellning av substituerade karboxitiazolo/3,2-a/pyrimidinderivat med en antiallergisk verkan. | |
| US3594378A (en) | Thiazolopyrimidine derivatives and preparation thereof | |
| FI74467C (fi) | Foerfarande foer framstaellning av 1,2,3,10-tetrahydro-10-oxo-cyklopenta/d/pyrido/1,2-a/pyrimidin- och 1,2,3,4-tetrahydro-11-oxo-11h-pyrido/2,1-b/kinazolinderivat. | |
| IE59728B1 (en) | Substituted 1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acids | |
| KR840000104B1 (ko) | 치환 피리도[1, 2-a] 피리미딘의 제조방법 | |
| US3989689A (en) | 4-Carbamoyl-1-benzazepines | |
| US3931151A (en) | Dibenzo (b,f) azepines | |
| JPH0122276B2 (cs) | ||
| US4978671A (en) | Thieno (3',4'-4,5)imidazo(2,1-b)thiazole derivatives, a process for their preparation and their use in medicaments | |
| NO166586B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalka-(b)-pyrazolo(3,4-d)-pyrridin-3-on-derivater. | |
| GB2119795A (en) | Condensed cycloaliphatic derivatives of substituted pyrido [1,2-a] pyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A |